Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-21

Clinical Trial Update: Mechanism of Action of Ustekinumab in Psoriatic Arthritis

View source ↗

Summary

Clinical trial update on the mechanism of action of ustekinumab in psoriatic arthritis. No clinical results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Arthritis, Psoriatic | Status: UNKNOWN